Life Science Incubation at LabCentral/BioLabs with Partners Extending from the USA to Europe
摘要
This chapter provides a blueprint for accelerating biotech and life sciences innovation using public–private partnerships to create innovation infrastructure that become a platform for scientific breakthroughs and economic growth. Examples are provided on creating standalone co-working labs as well as through partnerships with academic and healthcare system partners both in the United States and Europe. Risks and challenges are addressed as well as the overall benefits to the broader public of investing public funds in biotech and life science infrastructure versus individual companies based on the potential impact to global public health from new treatments, therapies, devices, and diagnostics.